Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Laurence Venat-Bouvet Olivier Trédan Camille Chakiba |
| Publication date | December 1, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |